Innate Pharma S.A. discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally.The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the. treatment of cutaneous T-cell and peripheral T-Cell lymphoma. Its products include Monalizumab, an immune checkpoint inhibitor that is in. Phase III clinical trial to treat colorectal and lung cancer.
